Alkermes plc (F:8AK) — Market Cap & Net Worth

$4.96 Billion USD · €4.25 Billion EUR · Rank #3607

Market Cap & Net Worth: Alkermes plc (8AK)

Alkermes plc (F:8AK) has a market capitalization of $4.96 Billion (€4.25 Billion) as of June 15, 2026. Listed on the F stock exchange, this Germany-based company holds position #3607 globally and #661 in its home market, demonstrating a 5.60% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Alkermes plc's stock price €38.50 by its total outstanding shares 166675807 (166.68 Million). Review how much debt does Alkermes plc carry to assess the company's total debt and financial obligations.

Alkermes plc Market Cap History: 2026 to 2026

Alkermes plc's market capitalization history from 2026 to 2026. Data shows growth from $7.50 Billion to $7.50 Billion (0.00% CAGR).

Alkermes plc Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Alkermes plc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

No P/S ratio data available

Latest Price to Earnings (P/E) Ratio

No P/E ratio data available

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
No financial ratio data available

Competitor Companies of 8AK by Market Capitalization

Companies near Alkermes plc in the global market cap rankings as of June 15, 2026.

Key companies related to Alkermes plc by market ranking:

Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #509 globally with a market cap of $52.60 Billion USD.
GALDERMA GROUP AG (NYSE:GALDY): Ranked #553 globally with a market cap of $48.78 Billion USD.
Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #598 globally with a market cap of $45.26 Billion USD ( CN¥309.32 Billion CNY).
Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #626 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#509	Takeda Pharmaceutical Co Ltd ADR	NYSE:TAK	$52.60 Billion	$16.65
#553	GALDERMA GROUP AG	NYSE:GALDY	$48.78 Billion	$43.31
#598	Jiangsu Hengrui Medicine Co Ltd	SHG:600276	$45.26 Billion	CN¥48.49
#626	Takeda Pharmaceutical Company Limited	F:TKDA	$43.60 Billion	€13.60

Alkermes plc Historical Marketcap From 2026 to 2026

Between 2026 and today, Alkermes plc's market cap moved from $7.50 Billion to $ 7.50 Billion, with a yearly change of 0.00%.

Year	Market Cap	Change (%)
2026	€7.50 Billion	--

End of Day Market Cap According to Different Sources

On Jun 15th, 2026 the market cap of Alkermes plc was reported to be:

Source	Market Cap
Yahoo Finance	$4.96 Billion USD
MoneyControl	$4.96 Billion USD
MarketWatch	$4.96 Billion USD
marketcap.company	$4.96 Billion USD
Reuters	$4.96 Billion USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Alkermes plc

F:8AK Germany Drug Manufacturers - Specialty & Generic

Market Cap

$7.50 Billion

€6.42 Billion EUR

Market Cap Rank

#3607 Global

#661 in Germany

Share Price

€38.50

Change (1 day)

+2.26%

52-Week Range

€23.40 - €38.50

All Time High

€38.50